Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now

By Alex Sirois, InvestorPlace Contributor
Investors should not ignore these highly rated stocks to buy now because they deserve their reputation as the market heats up.

The Dividend Goldmine: 3 Shining Stocks With Growing Payouts

By Yiannis Zourmpanos, InvestorPlace Contributor
Explore opportunities in the cable, restaurant and biotechnology sectors, revealing how dividend growth stocks are maximizing returns.

7 Stocks Under $15 Predicted to Boom in the Next 2 Years

By Yiannis Zourmpanos, InvestorPlace Contributor
Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.

Budding Opportunities: 3 Emerging Cannabis Markets to Explore 

By Matthew Farley, InvestorPlace Contributor
Discover three emerging cannabis markets with high growth potential. These regions are setting the stage for significant investment growth.

Is a Short Squeeze Brewing in Canopy Growth (CGC) Stock?

By Chris MacDonald, InvestorPlace Contributor
Shares of CGC stock are skyrocketing higher today as investors appear to be pricing in the potential for a short squeeze moving forward.

Recession-Proof Riches: 3 Stocks That Thrive in Any Economy

By Yiannis Zourmpanos, InvestorPlace Contributor
Discover recession-proof stocks that thrive amid economic uncertainty, offering stability and consistent growth.

ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal

By William White, InvestorPlace Writer
23andMe stock is rallying on Wednesday after the company's CEO announced plans to take ME shares private in a potential deal.

Why Is Bio-Path (BPTH) Stock Up 89% Today?

By William White, InvestorPlace Writer
Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.

Why Is NRX Pharmaceuticals (NRXP) Stock Down 29% Today?

By William White, InvestorPlace Writer
NRX Pharmaceuticals stock is down on Thursday after the company announced a public offering for NRXP shares after just avoiding delisting.

Unleash Your Portfolio: 3 Pet Stocks Poised to Fetch Big Returns

By Larry Ramer, InvestorPlace Contributor
With spending on pets rising quickly and largely resilient to economic pressures, these pet stocks should be quite profitable. 

The 3 Best Cannabis Stocks to Buy Now: Q2 Edition

By Ian Cooper, InvestorPlace Contributor
Cannabis stocks to buy now could see higher highs as we near elections -- especially with a growing number of Americans wanting legalization.

The Disruptor’s Portfolio: 3 Stocks Shaping the New Economy

By Yiannis Zourmpanos, InvestorPlace Contributor
Leading the future economy, three disruptive stocks innovate with SoCs, strategic alliances, and digital health growth.

Why Is Vanda Pharmaceuticals (VNDA) Stock Up 34% Today?

By William White, InvestorPlace Writer
Vanda Pharmaceuticals stock is heading higher on Wednesday as investors in VNDA learn of an acquisition offer for their shares.

Why Is Invo Bioscience (INVO) Stock Up 85% Today?

By William White, InvestorPlace Writer
Invo Bioscience stock is rising higher on Wednesday as INVO investors celebrate the company's latest earnings results for Q4 2023.

Coming FDA Approvals Could Send These 3 Drug Stocks Soaring

By Chandler Capital, InvestorPlace Contributor
When it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue.

Why Walmart Stock Is the Recession-Proof Powerhouse You Need in Your Portfolio Right Now

By David Moadel, InvestorPlace Contributor
Walmart stock is a safe and solid pick, as Walmart's broad-based business model will enable the company to withstand an economic downturn.

Cash Burn: 3 Dividend Aristocrats to Dump for Buyback Plays

By Matthew Farley, InvestorPlace Contributor
Discover why it might be time to trade dividend aristocrats for companies with aggressive buyback strategies for better capital gains.

The 3 Best Biotech Stocks to Buy Now: Q2 Edition

By Ian Cooper, InvestorPlace Contributor
Investors can find some of the hottest, most explosive opportunities in these three top biotech stocks to buy now.

3 Dow Stocks to Buy Now: Q2 Edition

By Josh Enomoto, InvestorPlace Contributor
Let’s be real – the narrative for Dow stocks to buy now tends to be one of relative safety. What are the chances that the…
Load More Articles